Stay updated on Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page.

Latest updates to the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page
- ChecktodayChange DetectedThe site revision number changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov record for this small-cell lung cancer study is displayed, including its study details, participation criteria, treatment plan, and outcome measures. It also includes the study protocol and statistical analysis plan.SummaryDifference53%

- Check21 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0; the page content remains a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedA site-wide notice about NIH’s terminology transition was added above the site navigation. The clinical trial record still displays a 403 error.SummaryDifference1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page remains a 403 Forbidden error, with the footer revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page.